These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18816596)

  • 1. Randomized trial to assess the efficacy of intraoperative steroid use in decreasing acute urinary retention after transperineal radioactive iodine-125 implantation for prostate cancer.
    Mierzwa ML; Barrett WL; Redmond K; Shirazi R; Kastl A; Kumar N; Buncher R
    Cancer; 2008 Nov; 113(9):2605-9. PubMed ID: 18816596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
    Mabjeesh NJ; Chen J; Stenger A; Matzkin H
    Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors of acute urinary retention requiring catheterization following 125I prostate brachytherapy.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T
    Jpn J Clin Oncol; 2006 May; 36(5):285-9. PubMed ID: 16698803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapy.
    Roeloffzen EM; Battermann JJ; van Deursen MJ; Monninkhof EM; Visscher MI; Moerland MA; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1072-9. PubMed ID: 20615621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods-preplanning and intraoperative planning.
    Matzkin H; Kaver I; Stenger A; Agai R; Esna N; Chen J
    Urology; 2003 Sep; 62(3):497-502. PubMed ID: 12946754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy.
    Lee N; Wuu CS; Brody R; Laguna JL; Katz AE; Bagiella E; Ennis RD
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1457-60. PubMed ID: 11121648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seed implant retention score predicts the risk of prolonged urinary retention after prostate brachytherapy.
    Lee HK; Adams MT; Shi Q; Basillote J; Lamonica J; Miranda L; Motta J
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1445-9. PubMed ID: 19553032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy.
    Martens C; Pond G; Webster D; McLean M; Gillan C; Crook J
    Brachytherapy; 2006; 5(1):9-13. PubMed ID: 16563992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid use after prostate brachytherapy reduces the risk of acute urinary retention.
    Sacco DE; Daller M; Grocela JA; Babayan RK; Zietman AL
    BJU Int; 2003 Mar; 91(4):345-9. PubMed ID: 12603412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy.
    Schwartz DJ; Schild SE; Wong WW; Vora SA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):60-3. PubMed ID: 15629594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Murray B; Allen Z; Lief JH; Galbreath RW
    Brachytherapy; 2004; 3(1):22-9. PubMed ID: 15110310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
    Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
    Sarosdy MF
    Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study.
    Locke J; Ellis W; Wallner K; Cavanagh W; Blasko J
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):712-9. PubMed ID: 11849794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.
    Elshaikh MA; Ulchaker JC; Reddy CA; Angermeier KW; Klein EA; Chehade N; Altman A; Ciezki JP
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):164-9. PubMed ID: 15850917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of urinary retention following prostate brachytherapy.
    Bucci J; Morris WJ; Keyes M; Spadinger I; Sidhu S; Moravan V
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):91-8. PubMed ID: 12007946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
    Gutman S; Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Adamovich E
    BJU Int; 2006 Jan; 97(1):62-8. PubMed ID: 16336330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nomogram to compensate for intraoperative prostate edema during transperineal brachytherapy.
    Potters L; Wang XH; Yamada Y
    Tech Urol; 2000 Jun; 6(2):99-103. PubMed ID: 10798808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase III randomized trial of the timing of meloxicam with iodine-125 prostate brachytherapy.
    Crook J; Patil N; Wallace K; Borg J; Zhou D; Ma C; Pond G
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):496-501. PubMed ID: 20350785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy.
    Williams SG; Millar JL; Duchesne GM; Dally MJ; Royce PL; Snow RM
    Radiother Oncol; 2004 Oct; 73(1):33-8. PubMed ID: 15465143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.